83 FR 55887 - Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 217 (November 8, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 217 (November 8, 2018)
| Page Range | 55887-55887 | |
| FR Document | 2018-24461 |
[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)] [Notices] [Page 55887] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-24461] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC) ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the CLIAC. The CLIAC, consists of 20 experts including the Chair in the fields associated with microbiology (including bacteriology, mycobacteriology, mycology, parasitology, and virology), immunology (including histocompatibility), chemistry, hematology, pathology (including histopathology and cytology), genetic testing (including cytogenetics); from representatives in the fields of medical technology, public health, and clinical practice; and from consumer representatives. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee's objectives. Nominees will be selected based on expertise in the fields of microbiology (including bacteriology, mycobacteriology, mycology, parasitology, and virology), immunology (including histocompatibility), chemistry, hematology, pathology (including histopathology and cytology), or genetic testing (including cytogenetics); from representatives in the fields of medical technology, public health, and clinical practice; and from consumer representatives. Members may be invited to serve for up to four-year terms. Selection of members is based on candidates' qualifications to contribute to the accomplishment of CLIAC objectives (https://www.cdc.gov/cliac/). DATES: Nominations for membership on the CLIAC must be received no later than May 1, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to Nancy Anderson, MMSc, MT(ASCP), CLIAC Secretary, Senior Advisor for Clinical Laboratories, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 30329-4018; telephone (404) 498-2741; or via email at [email protected] or faxed to (404) 471-2706. FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, Deputy Branch Chief, Quality and Safety Systems Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 30329-4018; telephone (404) 498-2769; [email protected]. SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee's function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees (SGEs), requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for CLIAC membership each year, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in July, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. SGE Nominees must be U.S. citizens. Candidates should submit the following items: [ssquf] Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address) [ssquf] At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018-24461 Filed 11-7-18; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 83, No. 217 / Thursday, November 8, 2018 / Notices 55887
October 5, 2018 Volume 83, Number or genetic testing (including slate of nominees for consideration to
194, page 50378. cytogenetics); from representatives in the Secretary of HHS for final selection.
The call-in number and passcode the fields of medical technology, public HHS notifies selected candidates of
should read as follows: call-in number, health, and clinical practice; and from their appointment near the start of the
866–803–2146, passcode: 80256461. consumer representatives. Members term in July, or as soon as the HHS
FOR FURTHER INFORMATION CONTACT: Erin may be invited to serve for up to four- selection process is completed. Note
Stone, M.A., HICPAC, Division of year terms. that the need for different expertise
Healthcare Quality Promotion, NCEZID, Selection of members is based on varies from year to year and a candidate
CDC, 1600 Clifton Road NE, Mailstop candidates’ qualifications to contribute who is not selected in one year may be
A–07, Atlanta, Georgia 30329–4027; to the accomplishment of CLIAC reconsidered in a subsequent year. SGE
Email: HICPAC@cdc.gov. objectives (https://www.cdc.gov/cliac/). Nominees must be U.S. citizens.
The Chief Operating Officer, Centers DATES: Nominations for membership on Candidates should submit the following
for Disease Control and Prevention, has the CLIAC must be received no later items:
been delegated the authority to sign than May 1, 2019. Packages received D Current curriculum vitae, including
Federal Register notices pertaining to after this time will not be considered for complete contact information
announcements of meetings and other the current membership cycle. (telephone numbers, mailing address,
committee management activities, for ADDRESSES: All nominations should be email address)
both the Centers for Disease Control and mailed to Nancy Anderson, MMSc, D At least one letter of
Prevention and the Agency for Toxic MT(ASCP), CLIAC Secretary, Senior recommendation from person(s) not
Substances and Disease Registry. Advisor for Clinical Laboratories, employed by the U.S. Department of
Division of Laboratory Systems, Center Health and Human Services.
Sherri Berger, (Candidates may submit letter(s) from
for Surveillance, Epidemiology and
Chief Operating Officer, Centers for Disease current HHS employees if they wish,
Control and Prevention.
Laboratory Services, Office of Public
Health Scientific Services, Centers for but at least one letter must be submitted
[FR Doc. 2018–24463 Filed 11–7–18; 8:45 am] by a person not employed by an HHS
Disease Control and Prevention, 1600
BILLING CODE 4163–18–P
Clifton Road NE, Mailstop V24–3, agency (e.g., CDC, NIH, FDA, etc.).
Atlanta, Georgia 30329–4018; telephone Nominations may be submitted by the
(404) 498–2741; or via email at candidate him- or herself, or by the
DEPARTMENT OF HEALTH AND person/organization recommending the
HUMAN SERVICES NAnderson@cdc.gov or faxed to (404)
471–2706. candidate.
The Chief Operating Officer, Centers
Centers for Disease Control and FOR FURTHER INFORMATION CONTACT:
for Disease Control and Prevention, has
Prevention Heather Stang, MS, Deputy Branch
been delegated the authority to sign
Chief, Quality and Safety Systems
Solicitation of Nominations for Federal Register notices pertaining to
Branch, Division of Laboratory Systems,
Appointment to the Clinical Laboratory announcements of meetings and other
Center for Surveillance, Epidemiology
Improvement Advisory Committee committee management activities for
and Laboratory Services, Office of
(CLIAC) both CDC and the Agency for Toxic
Public Health Scientific Services,
Substances and Disease Registry.
Centers for Disease Control and
ACTION: Notice. Prevention, 1600 Clifton Road NE, Sherri Berger,
SUMMARY: The Centers for Disease Mailstop V24–3, Atlanta, Georgia Chief Operating Officer, Centers for Disease
Control and Prevention (CDC) is seeking 30329–4018; telephone (404) 498–2769; Control and Prevention.
nominations for membership on the HStang@cdc.gov. [FR Doc. 2018–24461 Filed 11–7–18; 8:45 am]
CLIAC. The CLIAC, consists of 20 SUPPLEMENTARY INFORMATION: The U.S. BILLING CODE 4163–18–P
experts including the Chair in the fields Department of Health and Human
associated with microbiology (including Services policy stipulates that
bacteriology, mycobacteriology, committee membership be balanced in DEPARTMENT OF HEALTH AND
mycology, parasitology, and virology), terms of points of view represented, and HUMAN SERVICES
immunology (including the committee’s function. Appointments
histocompatibility), chemistry, shall be made without discrimination Centers for Disease Control and
hematology, pathology (including on the basis of age, race, ethnicity, Prevention
histopathology and cytology), genetic gender, sexual orientation, gender [Docket Number CDC–2018–0103, NIOSH–
testing (including cytogenetics); from identity, HIV status, disability, and 322]
representatives in the fields of medical cultural, religious, or socioeconomic
technology, public health, and clinical status. Nominees must be U.S. citizens. Draft—National Occupational Research
practice; and from consumer Current participation on federal Agenda for Immune, Infectious and
representatives. workgroups or prior experience serving Dermal Disease Prevention (IID)
Nominations are being sought for on a federal advisory committee does AGENCY: National Institute for
individuals who have expertise and not disqualify a candidate; however, Occupational Safety and Health
qualifications necessary to contribute to HHS policy is to avoid excessive (NIOSH) of the Centers for Disease
the accomplishments of the committee’s individual service on advisory Control and Prevention (CDC),
objectives. Nominees will be selected committees and multiple committee Department of Health and Human
daltland on DSKBBV9HB2PROD with NOTICES
based on expertise in the fields of memberships. Committee members are Services (HHS).
microbiology (including bacteriology, Special Government Employees (SGEs), ACTION: Request for comment.
mycobacteriology, mycology, requiring the filing of financial
parasitology, and virology), immunology disclosure reports at the beginning and SUMMARY: The National Institute for
(including histocompatibility), annually during their terms. CDC Occupational Safety and Health of the
chemistry, hematology, pathology reviews potential candidates for CLIAC Centers for Disease Control and
(including histopathology and cytology), membership each year, and provides a Prevention announces the availability of
VerDate Sep<11>2014 16:51 Nov 07, 2018 Jkt 247001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1](https://thefederalregister.org/doc/83_FR_56104/page/1.svg)
Document Created: 2018-11-08 06:23:02
Document Modified: 2018-11-08 06:23:02
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Nominations for membership on the CLIAC must be received no later than May 1, 2019. Packages received after this time will not be considered for the current membership cycle. | |
| Contact | Heather Stang, MS, Deputy Branch Chief, Quality and Safety Systems Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 30329-4018; telephone (404) 498-2769; [email protected] | |
| FR Citation | 83 FR 55887 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR